These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 34360650)
1. Chirality Matters: Biological Activity of Optically Pure Silybin and Its Congeners. Křen V Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360650 [TBL] [Abstract][Full Text] [Related]
2. Determination of Flavonolignan Compositional Ratios in Chen W; Zhao X; Huang Z; Luo S; Zhang X; Sun W; Lan T; He R Molecules; 2024 Jun; 29(13):. PubMed ID: 38998902 [TBL] [Abstract][Full Text] [Related]
3. Enhanced bioactivity of silybin B methylation products. Sy-Cordero AA; Graf TN; Runyon SP; Wani MC; Kroll DJ; Agarwal R; Brantley SJ; Paine MF; Polyak SJ; Oberlies NH Bioorg Med Chem; 2013 Feb; 21(3):742-7. PubMed ID: 23260576 [TBL] [Abstract][Full Text] [Related]
4. Biotransformation of Silymarin Flavonolignans by Human Fecal Microbiota. Valentová K; Havlík J; Kosina P; Papoušková B; Jaimes JD; Káňová K; Petrásková L; Ulrichová J; Křen V Metabolites; 2020 Jan; 10(1):. PubMed ID: 31936497 [TBL] [Abstract][Full Text] [Related]
5. In vitro antimicrobial and modulatory activity of the natural products silymarin and silibinin. de Oliveira DR; Tintino SR; Braga MF; Boligon AA; Athayde ML; Coutinho HD; de Menezes IR; Fachinetto R Biomed Res Int; 2015; 2015():292797. PubMed ID: 25866771 [TBL] [Abstract][Full Text] [Related]
6. Unveiling the healing properties of 2,3-dehydrosilychristin: a potential silymarin-derived flavonolignan from Tripathi N; Naik A; Kumar DN; Bhardwaj N; Goel B; Kumar S; Chakrabarty S; Ranjan A; Guru SK; Kumar S; Agrawal A; Jain SK Nat Prod Res; 2024 Feb; ():1-9. PubMed ID: 38333925 [TBL] [Abstract][Full Text] [Related]
8. A review of the botany, phytochemistry, pharmacology, synthetic biology and comprehensive utilization of Zhang X; Liu M; Wang Z; Wang P; Kong L; Wu J; Wu W; Ma L; Jiang S; Ren W; Du L; Ma W; Liu X Front Pharmacol; 2024; 15():1417655. PubMed ID: 39055491 [No Abstract] [Full Text] [Related]
9. cis-trans Isomerization of silybins A and B. Novotná M; Gažák R; Biedermann D; Di Meo F; Marhol P; Kuzma M; Bednárová L; Fuksová K; Trouillas P; Křen V Beilstein J Org Chem; 2014; 10():1047-1063. PubMed ID: 24991256 [TBL] [Abstract][Full Text] [Related]
10. New Aspects of Silibinin Stereoisomers and their 3-O-galloyl Derivatives on Cytotoxicity and Ceramide Metabolism in Hep G Mashhadi Akbar Boojar M; Hassanipour M; Ejtemaei Mehr S; Mashhadi Akbar Boojar M; Dehpour AR Iran J Pharm Res; 2016; 15(3):421-433. PubMed ID: 27980577 [TBL] [Abstract][Full Text] [Related]
11. Total Synthesis of (+)-Silybin A. Inai M; Sagara H; Ueno Y; Ouchi H; Yoshimura F; Asakawa T; Hamashima Y; Kan T Chem Pharm Bull (Tokyo); 2024; 72(6):570-573. PubMed ID: 38910121 [TBL] [Abstract][Full Text] [Related]
12. Silybin and its congeners: from traditional medicine to molecular effects. Křen V; Valentová K Nat Prod Rep; 2022 Jun; 39(6):1264-1281. PubMed ID: 35510639 [TBL] [Abstract][Full Text] [Related]
13. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. Koltai T; Fliegel L J Evid Based Integr Med; 2022; 27():2515690X211068826. PubMed ID: 35018864 [TBL] [Abstract][Full Text] [Related]